Companies Sued For Ozempic or Other GLP-1 Injury Defendants named in GLP-1 injury lawsuits have included manufacturers, sellers and/or distributors of various GLP-1 receptor agonist medications, including: Novo Nordisk (Ozempic, Rybelsus, Wegovy, Saxenda) Eli Lilly (Mounjaro, Zepbound, Trulicity) Other GLP-1 injury defendants Ozempic GLP-1 Lawsuit & Settlement Updates Recent updates about Ozempic lawsuits and settlements include: July 2026: GLP-1 lawsuits remain active in federal and state courts
Further insight into the effects of semaglutide in patients who receive background SGLT2 inhibitors will be provided by the STEP-HFpEF DM trial, which includes a greater proportion (32%) of patients taking these agents 12
:
Notable improvements typically emerge within a few days of each session, with cumulative enhancement by the end of a 35 treatment course
Negative experiences The negative reviews paint a more concerning picture
The new products highlight a growing trend in the weight loss medication space: food products tailored for GLP-1 users, a market that has seen activity from companies like Nestl, Daily Harvest, and Smoothie King Hims & Hers Health, Inc